Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter van Dam

Showing results (41-50 of 112) with videos related to

Pageof 12
Sort By:
Journal of Fungi (Basel, Switzerland)|June 25, 2025
Long-Read Draft Genome Sequences of Two <i>Fusarium oxysporum</i> f. sp. <i>cubense</i> Isolates from Banana (<i>Musa</i> spp.)Jiaman Sun, Jinzhong Zhang, Donald M Gardiner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 9, 2024
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)Rita Trozzi, Sandra Tuyaerts, Daniela Annibali, et al.
Computing in Cardiology|October 6, 2023
The Effect of Segmentation Variability in Forward ECG SimulationBeata Ondrusova, Machteld Boonstra, Jana Svehlikova, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)Rita Trozzi, Sandra Tuyaerts, Daniela Annibali, et al.
Pharmacology & Therapeutics|January 9, 2022
Targeting hedgehog signaling in pancreatic ductal adenocarcinomaDelphine Quatannens, Yannick Verhoeven, Peter Van Dam, et al.
BMC Genomics|September 20, 2017
Mitochondrial genomes reveal recombination in the presumed asexual Fusarium oxysporum species complexBalázs Brankovics, Peter van Dam, Martijn Rep, et al.
Breast Cancer Research : BCR|March 4, 2005
Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancerIna H Benoy, Roberto Salgado, Hilde Elst, et al.
Scientific Reports|August 24, 2017
A mobile pathogenicity chromosome in Fusarium oxysporum for infection of multiple cucurbit speciesPeter van Dam, Like Fokkens, Yu Ayukawa, et al.
Clinical Breast Cancer|June 28, 2006
Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancerIna H Benoy, Hilde Elst, Marita Philips, et al.
Journal of Electrocardiology|October 8, 2017
Debatable issues in automated ECG reportingPeter W Macfarlane, Jay W Mason, Paul Kligfield, et al.
Pageof 12

Showing results (41-50 of 112) with videos related to

Sort By:
Pageof 12
Journal of Fungi (Basel, Switzerland)|June 25, 2025
Long-Read Draft Genome Sequences of Two <i>Fusarium oxysporum</i> f. sp. <i>cubense</i> Isolates from Banana (<i>Musa</i> spp.)Jiaman Sun, Jinzhong Zhang, Donald M Gardiner, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 9, 2024
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)Rita Trozzi, Sandra Tuyaerts, Daniela Annibali, et al.
Computing in Cardiology|October 6, 2023
The Effect of Segmentation Variability in Forward ECG SimulationBeata Ondrusova, Machteld Boonstra, Jana Svehlikova, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
An open-label, single-arm, prospective, multi-center, tandem two-stage designed phase II study to evaluate the efficacy of fulvestrant in women with recurrent/metastatic estrogen receptor-positive gynecological malignancies (FUCHSia study)Rita Trozzi, Sandra Tuyaerts, Daniela Annibali, et al.
Pharmacology & Therapeutics|January 9, 2022
Targeting hedgehog signaling in pancreatic ductal adenocarcinomaDelphine Quatannens, Yannick Verhoeven, Peter Van Dam, et al.
BMC Genomics|September 20, 2017
Mitochondrial genomes reveal recombination in the presumed asexual Fusarium oxysporum species complexBalázs Brankovics, Peter van Dam, Martijn Rep, et al.
Breast Cancer Research : BCR|March 4, 2005
Relative microvessel area of the primary tumour, and not lymph node status, predicts the presence of bone marrow micrometastases detected by reverse transcriptase polymerase chain reaction in patients with clinically non-metastatic breast cancerIna H Benoy, Roberto Salgado, Hilde Elst, et al.
Scientific Reports|August 24, 2017
A mobile pathogenicity chromosome in Fusarium oxysporum for infection of multiple cucurbit speciesPeter van Dam, Like Fokkens, Yu Ayukawa, et al.
Clinical Breast Cancer|June 28, 2006
Prognostic significance of disseminated tumor cells as detected by quantitative real-time reverse-transcriptase polymerase chain reaction in patients with breast cancerIna H Benoy, Hilde Elst, Marita Philips, et al.
Journal of Electrocardiology|October 8, 2017
Debatable issues in automated ECG reportingPeter W Macfarlane, Jay W Mason, Paul Kligfield, et al.
Pageof 12